Skip Nav Destination
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy
NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia
Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II
Trends in survival of young adult patients with acute lymphoblastic leukemia in Sweden and the United States
Issue Archive
Table of Contents
BLOOD COMMENTARIES
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy
Clinical Trials & Observations
Emanuele Zucca,Stephanie Rondeau,Anna Vanazzi,Bjørn Østenstad,Ulrich J. M. Mey,Daniel Rauch,Björn E. Wahlin,Felicitas Hitz,Micaela Hernberg,Ann-Sofie Johansson,Peter de Nully Brown,Hans Hagberg,Andrés J. M. Ferreri,Andreas Lohri,Urban Novak,Thilo Zander,Hanne Bersvendsen,Mario Bargetzi,Walter Mingrone,Fatime Krasniqi,Stefan Dirnhofer,Stefanie Hayoz,Hanne Hawle,Simona Berardi Vilei,Michele Ghielmini,Eva Kimby,for the Swiss Group for Clinical Cancer Research and the Nordic Lymphoma Group
LYMPHOID NEOPLASIA
Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma
Xiaosheng Wu,Mary Stenson,Jithma Abeykoon,Kevin Nowakowski,Lianwen Zhang,Joshua Lawson,Linda Wellik,Ying Li,Jordan Krull,Kerstin Wenzl,Anne J. Novak,Stephen M. Ansell,Gail A. Bishop,Daniel D. Billadeau,Kah Whye Peng,Francis Giles,Daniel M. Schmitt,Thomas E. Witzig
There is a Blood Commentary on this article in this issue.
MYELOID NEOPLASIA
NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia
Brief Report
Alina Rudorf,Tony Andreas Müller,Cathrin Klingeberg,Stefanie Kreutmair,Teresa Poggio,Sivahari Prasad Gorantla,Tamina Rückert,Annette Schmitt-Graeff,Anina Gengenbacher,Peter Paschka,Claudia Baldus,Robert Zeiser,George S. Vassiliou,Allan Bradley,Justus Duyster,Anna Lena Illert
Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II
Brief Report
Courtney L. Jones,Brett M. Stevens,Angelo D’Alessandro,Rachel Culp-Hill,Julie A. Reisz,Shanshan Pei,Annika Gustafson,Nabilah Khan,James DeGregori,Daniel A. Pollyea,Craig T. Jordan
There is a Blood Commentary on this article in this issue.
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2
Carmelo Carmona-Rivera,Sami S. Khaznadar,Kyawt W. Shwin,Jorge A. Irizarry-Caro,Liam J. O’Neil,Yudong Liu,Kenneth A. Jacobson,Amanda K. Ombrello,Deborah L. Stone,Wanxia L. Tsai,Daniel L. Kastner,Ivona Aksentijevich,Mariana J. Kaplan,Peter C. Grayson
There is a Blood Commentary on this article in this issue.
LETTER TO BLOOD
Trends in survival of young adult patients with acute lymphoblastic leukemia in Sweden and the United States
Clinical Trials & Observations
BLOOD WORK
-
Cover Image
Cover Image
Immunofluorescence photomicrograph of neutrophil extracellular traps (NETs, in red) triggered by exposure of neutrophils to 16 μM adenosine for 4 hours. Adenosine-mediated NET formation is implicated in a monogenic form of vasculitis known as deficiency of adenosine deaminase 2 (DADA2). See the article by Carmona-Rivera et al on page 395.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals